Pre-Exposure Prophylaxis: Clinical Trials

3 trials of Pre-Exposure Prophylaxis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Recruiting 2, Completed 1

Follow Pre-Exposure Prophylaxis: new trials by email Literature Review of Pre-Exposure Prophylaxis trials Research Report on Pre-Exposure Prophylaxis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MAPS PrEP Van Study
Pre-Exposure Prophylaxis (PrEP) - HIV Infection
Phase 4CompletedDuke University72025-09-172026-07-24
Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP
community-friendly health recovery program, Pre-Exposure Prophylaxis and Post-Exposure Prophylaxis - Hiv, Opioid Use Disorder
Phase 4RecruitingUniversity of Connecticut2562023-03-012026-06-15
ANCHORS Alcohol & Sexual Health Study: UH3 Project
PrEP acronym (pre-exposure prophylaxis), Initial Web Survey, Interactive Voice Response (IVR) monitoring - Alcohol Use, Unspecified, Substance Use
Phase 4RecruitingUniversity of Florida882021-01-122025-07-10

Conditions studied

Acquired Immunodeficiency Syndrome (1)  ·  Alcohol Drinking (1)  ·  Cognitive Dysfunction (1)  ·  HIV Infections (1)  ·  Opioid-Related Disorders (1)  ·  Sexual Behavior (1)  ·  Substance-Related Disorders (1)

Sponsors

Duke University (1)  ·  University of Connecticut (1)  ·  University of Florida (1)

Countries

United States (3)

Top investigators

Jacqueline Hodges, MD, MPH (1)  ·  Mehri McKellar, MD (1)  ·  Michael Copenhaver, PhD (1)  ·  Robert L. Cook, PhD (1)

Results publications

PMID 37399447

NIH funding

F31AA028751 (1), P30AI064518 (1), UH3AA026214 (1)